Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CAD | Fiscal Year Ending | | Latest |
(in millions) | Apr-15 | Apr-16 | Apr-17 | Apr-18 | Apr-19 | Apr-20 | Apr-21 | Apr-22 | Apr-23 | Apr-24 | | Jan-25 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
% Growth | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | |
| | | | | | | | | | | | |
Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
% Revenue | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | NA |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (0) | (0) | (0) | (1) | (0) | (1) | (1) | (1) | (1) | (0) | | (1) |
Other Inc / (Exp) | (0) | (0) | (0) | (0) | (0) | 0 | (1) | 0 | (3) | 0 | | 0 |
Total Operating Exp | (0) | (0) | (0) | (1) | (1) | (1) | (2) | (1) | (4) | (0) | | (0) |
| | | | | | | | | | | | |
Operating Income | (0) | (0) | (0) | (1) | (1) | (1) | (2) | (1) | (4) | (0) | | (0) |
% Revenue | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | NA |
| | | | | | | | | | | | |
Interest Expense | (0) | (0) | (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Pre-tax Income | (0) | (0) | (0) | (1) | (1) | (1) | (2) | (1) | (4) | (0) | | (0) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Company | (0) | (0) | (0) | (1) | (1) | (1) | (2) | (1) | (4) | (0) | | (0) |
% Margin | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | NA |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | (0) | (0) | (0) | (1) | (1) | (1) | (2) | (1) | (4) | (0) | | (0) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | (0) | (0) | (0) | (1) | (1) | (1) | (2) | (1) | (4) | (0) | | (0) |
% Margin | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | NA |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | (0.03) | (0.01) | (0.05) | (0.03) | (0.02) | (0.01) | (0.02) | (0.01) | (0.03) | (0.00) | | (0.00) |
Diluted EPS (Continuing Ops) | (0.03) | (0.01) | (0.05) | (0.03) | (0.02) | (0.01) | (0.02) | (0.01) | (0.03) | (0.00) | | (0.00) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 2.55 | 2.55 | 2.55 | 19.76 | 40.77 | 71.71 | 97.76 | 107.62 | 122.36 | 143.11 | | 147.34 |
WA Diluted Shares Out. | 2.55 | 2.55 | 2.55 | 19.76 | 40.77 | 71.71 | 97.76 | 107.62 | 122.36 | 143.11 | | 147.34 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (0) | (0) | (0) | (1) | (1) | (1) | (2) | (1) | (4) | (0) | | (0) |
Addback: Net Interest Expense | 0 | 0 | 0 | 0 | 0 | (0) | (0) | 0 | 0 | (0) | | (0) |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | (0) | (0) | (0) | (0) | 0 | 0 | | 0 |
Addback: Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | | 1 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | (0) | | (0) |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | (0) | 0 | (0) | (1) | (0) | (1) | (1) | (0) | (1) | 2 | | (0) |
% Margin | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | NA |
| | | | | | | | | | | | |
Adjusted EBIT | (0) | (0) | (0) | (1) | (1) | (1) | (2) | (1) | (3) | (0) | | (1) |
% Margin | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | NA |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | (0) | (0) | (0) | (1) | (1) | (1) | (2) | (1) | (4) | (0) | | (0) |
Addback: Unusual Items | 0 | 0 | (0) | 0 | 0 | 0 | 0 | 0 | 1 | (0) | | (0) |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 0 | | 0 |
Adjusted Net Income | (0) | (0) | (0) | (1) | (1) | (1) | (2) | (1) | (3) | (0) | | (1) |
% Margin | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | | NA |